Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07459556
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
Sponsor: Chengdu Kangnuoxing Biopharma,Inc.
View on ClinicalTrials.gov
Summary
This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.
Official title: A Prospective Study of Stapokibart Injection in Patients With SAR
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2026-03
Completion Date
2028-02
Last Updated
2026-03-09
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
Stapokibart
subcutaneous injection
Locations (1)
Beijing Tongren Hospital, CMU
Beijing, China